Medtech darling Vaxxas now set to launch $100m raise

BRISBANE: Home-grown medtech Vaxxas, which wants to disrupt the 170-year-old method of delivering ... read more
ResMed soars on earnings uplift above analyst expectations

SYDNEY: As expected, ResMed’s CHESS depositary interests have jumped in early trading following ... read more